Circulating Level of miR-378 Predicts Left Ventricular Hypertrophy in Patients with Aortic Stenosis
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
AIMS: Excessively high left ventricle mass is an independent predictor of adverse prognosis. MicroRNAs (miRs) play crucial roles in the regulation of left ventricle hypertrophy (LVH). However, few circulating miRs have been established as predictors of LVH in aortic stenosis (AS) patients. In this study, we aimed to investigate whether circulating levels of miR-1, miR-133, and miR-378 predict LVH in patients with AS. METHODS AND RESULTS: One-hundred twelve patients with moderate to severe AS and 40 healthy controls were included in the study. Levels of miR-1, miR-133, and miR-378 in the plasma were measured by qPCR. Compared with healthy controls, AS patients had significantly lower circulating levels of miR-1, miR-133, and miR-378. AS patients with LVH had significantly lower miR-378 but not miR-1 and miR-133 compared with those without LVH. Linear regression analysis showed circulating miR-378 had strong correlation with left ventricular mass index (r = 0.283, p = 0.002) and logistic regression showed that lower miR-378 was an independent predictor for LVH in patients with AS (p = 0.037, OR 4.110, 95% CI 1.086 to 15.558). CONCLUSION: Circulating levels of miR-1, miR-133 and miR-378 were decreased in AS patients, and miR-378 predicts LVH independent of the pressure gradient. Further prospective investigations are needed to elucidate whether these circulating miRs affect clinical outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Emerging blood biomarkers, such high-sensitivity cardiac troponin194;195, growth/differentiation factor 15, soluble interleukin-1 receptor-like 1 (also called protein ST2) and micro RNAs196–198, might be helpful to detect subclinical and/or irreversible myocardial dysfunction”
From Calcific aortic stenosis (2016) · cites this paper as [196]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“but their incremental value beyond already established clinical, echocardiographic, tomographic and blood biomarkers is yet to be demonstrated.”
From Calcific aortic stenosis (2016) · cites this paper as [196]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
A Cardiac-enriched MicroRNA, miR-378, Blocks Cardiac Hypertrophy by Targeting Ras Signaling
Nagalingam, R. S., Sundaresan, N. R., Gupta, M. P., Geenen, D. L., Solaro, R. J., & Gupta, M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.442384 · Cited by 89
RetractedBonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O’Gara, P. T., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.176857 · Cited by 8,495
Circulating microRNAs as stable blood-based markers for cancer detection
Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., Peterson, A., Noteboom, J., O'Briant, K. C., Allen, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804549105 · Cited by 7,969
MicroRNAs: small RNAs with a big role in gene regulation
He, L., & Hannon, G. J. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1379 · Cited by 7,118
Oncomirs—MicroRNAs with a role in cancer
Esquela-Kerscher, A., & Slack, F. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1840 · Cited by 5,884
Burden of valvular heart diseases: a population-based study
Nkomo, V. T., Gardin, J. M., Skelton, T. N., Gottdiener, J. S., Scott, C. G., & Enriquez-Sarano, M. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69208-8 · Cited by 4,881
Recommendations for chamber quantification☆
LANG, R., BIERIG, M., DEVEREUX, R., FLACHSKAMPF, F., FOSTER, E., PELLIKKA, P., PICARD, M., ROMAN, M., SEWARD, J., & SHANEWISE, J. (2006) · European Journal of Echocardiography · doi:10.1016/j.euje.2005.12.014 · Cited by 3,571
Iung, B. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00201-x · Cited by 3,530 · cited 1×
“Aortic stenosis (AS) is a common valve disorder that account for 43% of valvular heart diseases in adult patients [1].”
BackgroundThe role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation
Chen, J.-F., Mandel, E. M., Thomson, J. M., Wu, Q., Callis, T. E., Hammond, S. M., Conlon, F. L., & Wang, D.-Z. (2006) · Nature Genetics · doi:10.1038/ng1725 · Cited by 2,779
Gene silencing by microRNAs: contributions of translational repression and mRNA decay
Huntzinger, E., & Izaurralde, E. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2936 · Cited by 2,339 · cited 1×
“Micro-RNAs (miRs) are non-coding RNA molecules of ,22 nucleotides that function as a mechanism for negative posttranscriptional regulation [10].”
Background
Cited by
Lindman, B. R., Clavel, M.-A., Mathieu, P., Iung, B., Lancellotti, P., Otto, C. M., & Pibarot, P. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.6 · Cited by 982
Opportunities for microRNAs in the crowded field of cardiovascular biomarkers
Halushka, P. V., Goodwin, A. J., & Halushka, M. K. (2019) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012827 · Cited by 84
Shah, P. M., Bristow, M. R., & Port, J. D. (2017) · Current Heart Failure Reports · doi:10.1007/s11897-017-0362-8 · Cited by 66
Bär, C., Chatterjee, S., Falcão‐Pires, I., Gonçalves‐Rodrigues, P., Sluijter, J. P. G., Boon, R. A., Nevado, R. M., Andrés, V., Sansonetti, M., Windt, L. J. D., et al. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa195 · Cited by 61
Impact of MicroRNAs in the Cellular Response to Hypoxia
Bertero, T., Rezzonico, R., Pottier, N., & Mari, B. P. (2017) · International review of cytology · doi:10.1016/bs.ircmb.2017.03.006 · Cited by 61
Myocardial microRNAs associated with reverse remodeling in human heart failure
Sucharov, C. C., Kao, D. P., Port, J. D., Karimpour‐Fard, A., Quaife, R. A., Minobe, W. A., Nunley, K. R., Lowes, B. D., Gilbert, E. M., & Bristow, M. R. (2017) · JCI Insight · doi:10.1172/jci.insight.89169 · Cited by 54
Oury, C., Servais, L., Bouznad, N., Hego, A., Nchimi, A., & Lancellotti, P. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17071120 · Cited by 43
Coffey, S., Williams, M. J. A., Phillips, L. V., & Jones, G. T. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002150 · Cited by 39
The Genetic Regulation of Aortic Valve Development and Calcific Disease
Menon, V., & Lincoln, J. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00162 · Cited by 42
Sun, J., Cheng, W., Liu, L., Tao, S., Xia, Z., Qi, L., & Huang, M. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5906 · Cited by 36
Epigenome alterations in aortic valve stenosis and its related left ventricular hypertrophy
Gošev, I., Zeljko, M., Đurić, Ž., Nikolić, I., Gošev, M., Ivčević, S., Bešić, D., Legčević, Z., & Paić, F. (2017) · Clinical Epigenetics · doi:10.1186/s13148-017-0406-7 · Cited by 36
MicroRNAs fingerprint of bicuspid aortic valve
Sabatino, J., Wicik, Z., Rosa, S. D., Eyileten, C., Jakubik, D., Spaccarotella, C., Mongiardo, A., Postula, M. A., & Indolfi, C. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.07.001 · Cited by 32
Huang, D., Chen, Z., Wang, J., Chen, Y., Liu, D., & Lin, K. (2020) · Bioscience Reports · doi:10.1042/bsr20191234 · Cited by 32
Self-citationNon-Coding RNAs as Blood-Based Biomarkers in Cardiovascular Disease
Videira, R. F., Martins, P. A. D. C., & Falcão‐Pires, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239285 · Cited by 25
Kaneto, C. M., Nascimento, J. S., Moreira, M. C. R., Ludovico, N. D., Santana, A. P., Silva, R. A. A., Silva-Jardim, I., dos Santos, J. L., Sousa, S. M. B., & Lima, P. (2017) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20176211 · Cited by 24
Pasipoularides, A. D. (2016) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-016-9695-z · Cited by 23
Protective effect of miR378* on doxorubicin‐induced cardiomyocyte injury via calumenin
Wang, Y., Cui, X., Wang, Y., Fu, Y. S., Guo, X., Long, J., Wei, C., & Zhao, M. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26615 · Cited by 22
Blood, tissue and imaging biomarkers in calcific aortic valve stenosis: past, present and future
Shen, M., Tastet, L. L., Bergler-Klein, J. K., Pîbarot, P., & Clavel, M.-A. A. (2017) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000487 · Cited by 23
Bio‐based benzoxazine monomers and polymers based on difuran diamine
Yu, M., Yadav, S. K., Scala, J. J. L., & Palmese, G. R. (2022) · Journal of Applied Polymer Science · doi:10.1002/app.52946 · Cited by 16
Blood biomarkers in left-sided valvular heart disease
Coisne, A., Lancellotti, P., Côté, N., Ternacle, J., Hecht, S., Grapsa, J., Hahn, R. T., Clavel, M.-A. A., Vannan, M. A., Lindman, B. R., et al. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf232 · Cited by 19
Overexpression of miR-378 Alleviates Chronic Sciatic Nerve Injury by Targeting EZH2
Gao, P., Zeng, X., Zhang, L., Wang, L., Shen, L., Hou, Y., Zhou, F., & Zhang, X. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03424-9 · Cited by 14
The Role of MicroRNAs in Aortic Stenosis—Lessons from Recent Clinical Research Studies
Krauze, A., Procyk, G., Gąsecka, A., Garstka-Pacak, I., & Wrzosek, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713095 · Cited by 11
Calogero, E., Fabiani, I., Conte, L., Matteo, P., Riccardo, P., Veronica, S., Barletta, V., Liga, R., Scatena, C., Maria, M., et al. (2016) · Journal of Cardiovascular Echography · doi:10.4103/2211-4122.192132 · Cited by 9
Ade, C. J., & Bemben, D. A. (2019) · Physiological Reports · doi:10.14814/phy2.14061 · Cited by 9
Sánchez-Gómez, M. C., García-Mejía, K. A., Conti, M. P.-D., Díaz-Rosas, G., Lara, I. P., Sánchez‐Urbina, R., Klünder‐Klünder, M., Botello-Flores, Y. A., Balderrábano-Saucedo, N., & Contreras‐Ramos, A. (2017) · Pediatric Cardiology · doi:10.1007/s00246-017-1607-8 · Cited by 8
MicroRNA‑378: An important player in cardiovascular diseases (Review)
Wang, H., Shi, J., Wang, J., & Hu, Y. (2023) · Molecular Medicine Reports · doi:10.3892/mmr.2023.13059 · Cited by 8
Aortic Stenosis: Diagnosis, Molecular Mechanisms and Therapeutic Strategies—A Comprehensive Review
Banceu, C. M., Cristutiu, D., Gurzu, S., Harpa, M. M., Banceu, D. M., & Suciu, H. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14144949 · Cited by 9
Gabriel, A. F., Costa, M. C., Caldeira, D., Plácido, R., Rigueira, J., Carrilho‐Ferreira, P., Gonçalves, S., Ferreira, R., Nobre, Â. L., Pinto, F. J., et al. (2024) · European Heart Journal Open · doi:10.1093/ehjopen/oeae060 · Cited by 7
Asymptomatic severe aortic stenosis with normal left ventricular function – A review
Sathyamurthy, I., & B, J. K. (2016) · Indian Heart Journal · doi:10.1016/j.ihj.2016.05.006 · Cited by 4
Banovic, M. D. (2017) · Biomarkers in Medicine · doi:10.2217/bmm-2016-0369 · Cited by 3
MicroRNA-133: Biomarker and Mediator of Cardiovascular Diseases
Nistal, J. F., Villar, A. V., García, R., & Hurlé, M. A. (2016) · Springer eBooks · doi:10.1007/978-94-007-7678-4_28 · Cited by 4
MicroRNA-133: Biomarker and Mediator of Cardiovascular Diseases
Nistal, J. F., Villar, A. V., García, R., & Hurlé, M. A. (2015) · Springer eBooks · doi:10.1007/978-94-007-7741-5_28-1 · Cited by 2
Ramos, M., Enguita, F. J., Bonet, F., Ayala, R., Gómez‐Pavón, J., Campuzano, Ó., Toro, R., & Quezada-Feijoó, M. (2025) · Biomedicines · doi:10.3390/biomedicines13030671 · Cited by 1
A Multi-Omics Approach to Defining the Target Organ Injury in Youth with Primary Hypertension
Ananthamohan, K., Brady, T. M., Arif, M., Daniels, S., Falkner, B. E., Ferguson, M. A., Flynn, J. T., Hanevold, C. D., Hooper, S. R., Ingelfinger, J. R., et al. (2025) · Journal of Molecular and Cellular Cardiology Plus · doi:10.1016/j.jmccpl.2025.100339 · Cited by 1
Videira, R. F. (2022) · Research Publications (Maastricht University) · doi:10.26481/dis.20220711rv · Cited by 1
Prospects of using miRNA-378 as a biomarker for cardiovascular diseases: A literature review
Alieva, A. M., Khadzhieva, N. K., Baykova, I. E., Rakhaev, A. M., Kotikova, I. A., & Nikitin, I. G. (2024) · Cardiosomatics · doi:10.17816/cs632226
Metadata
- Authors
- Chen, Z., Li, C., Xu, Y., Li, Y., Yang, H., & Rao, L.
- Affiliations
- West China Hospital of Sichuan University (CN)
- Corresponding author
- Rao, Li
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-08-26
- Volume
- 9
- Issue
- 8
- Pages
- e105702
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4144890
- OpenAlex
- W2056851893
- Cited by
- 36
- References
- 41
- Citations by year
- 2025: 4 · 2024: 2 · 2023: 2 · 2022: 2 · 2021: 1 · 2020: 3 · 2019: 2 · 2018: 3 · 2017: 8 · 2016: 7 · 2015: 2
- FWCI
- 1.82
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (81270289, 81300169)
- Ministry of Education of the People's Republic of China
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- miR-378, left ventricular hypertrophy, aortic stenosis, circulating microRNAs, miR-1, miR-133, left ventricular mass index, biomarkers, prognosis
- MeSH terms
- Adult, Aortic Valve Stenosis, Female, Humans, Male, Middle Aged, Biomarkers, Case-Control Studies, Hypertrophy, Left Ventricular, MicroRNAs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.